During the forecast period 2023-2033, the IgA Nephropathy Market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney …
Category Archives: Healthcare Trends
Trimethoprim is expected to capture 40% of the Chronic Granulomatous Disease Market | FMI study
During the forecast period 2023-2033, the Chronic Granulomatous Disease (CGD) Management Market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Granulomatous disease (CGD) management is expected to rise up to a market valuation of US$ 2.11 Billion. It is …
Intestinal Fistula Treatment Market is expected to reach US$ 46.82 Billion | FMI
The global Intestinal Fistula Treatment Market is expected to be valued at US$ 26.64 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for intestinal fistula treatment is projected to grow at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 46.82 Billion by 2033. Factors such as …
Continue reading “Intestinal Fistula Treatment Market is expected to reach US$ 46.82 Billion | FMI”
Prinzmetal Angina Therapeutics Market is expected to reach a valuation of US$ 17.2 Billion by 2033 | FMI Report
The global Prinzmetal Angina Therapeutics Market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of …
Oncolytic Virus Cancer Therapy Market is expected to be worth US$ 250 million by 2033 | FMI Analyst
According to a recent study published by Future Market Insights, the market for Oncolytic Virus Cancer Therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise …
Myotonic Dystrophy Treatment Market is expected to reach US$ 2,789.35 million by 2033 | FMI
The global Myotonic Dystrophy Treatment Market size is expected to be valued at US$ 874.39 Million in 2023. With the strategic initiative adopted by market players and strict regulatory framework, the overall demand for Myotonic Dystrophy Treatment is projected to grow at a CAGR of 12.3% between 2023 and 2033, totaling around US$ 2,789.35 Million …
Combined Sales of Hyaluronic Acid Personal Care Products is likely to cross US$ 7.36 billion by 2033. Increasing Consumer Consciousness of Skin Care Impacts the Demand for Hyaluronic Acid Personal Care Products.
In 2033, the global market for hyaluronic acid personal care products is expected to reach US$ 7.36 billion, up from US$ 3.26 billion in 2023. This market is expected to register an 8.5% CAGR over the next few years, due to growing concerns about the appearance of aging populations. It is easy to purchase these …
Combined Sales of Infertility Drugs Market Will Cross US$ 6,814.68 million by 2033; Ovulation Disorder is Leading to a Rise in Demand for Infertility Drugs.
The global infertility drugs market size was valued at US$ 3,699.8 million in the year 2023 and is projected to grow to US$ 6,814.68 million by 2033. This market is expected to register a CAGR of 6.3% during the analysis period. Due to the increase in infertility, a rise in the demand for infertility drugs …
Pleural Disease Therapeutics Market to reach US$ 9.4 billion in 2033, Thoracentesis based Treatment to account for 34% Revenue: FMI
A recently published study by Future Market Insights, the global pleural disease therapeutics market is expected to accumulate a valuation of US$ 9.4 billion by 2033, registering a CAGR of 6.5% across the forthcoming decade. Increasing prevalence of congestive heart failure, and other heart conditions, lung conditions, pneumonia, cancer and tuberculosis is estimated to propel …
Global Optic Atrophy Management Market to surpass US$ 15 billion by 2033, growing at a 4.9% CAGR: FMI Study
According to Future Market Insights, the optic atrophy management market is slated to experience a CAGR of 4.9% from 2023 to 2033, anticipated to reach a valuation of US$ 15.63 billion. An existing medical study in gene replacement therapy found a satisfactory safety record but poor medicinal result durability. The findings of the study are …